National Retina Institute - Market Research Report

Company Overview

• Name: National Retina Institute

• Mission: Changing the way people see the world; Leaders in the Treatment of Retinal Diseases.

• Founded By: Dr. Bert M. Glaser

• Year Founded: No information is available

• Key People:

• Dr. Bert M. Glaser, Founder

• Dr. Olga Shif, M.D

• Headquarters: Owings Mills, Maryland

• Number of Employees: No information is available

• Revenue: No information is available

• Known For: Specializes in the treatment, research, and clinical trials for complex disorders related to the retina, vitreous, and macula. They provide state-of-the-art treatment, ensuring high quality and equitable care while focusing on inclusion and diversity.

Products and Services

Products and Services Offered

1. Macular Degeneration

• Description: Treatment and diagnostics for macular degeneration, one of the leading causes of vision loss.

• Key Features:

• Utilizes industry-leading technologies such as OCT, Fundus Photography, and innovative treatment methods.

2. Diabetic Retinopathy

• Description: Specialized care for diabetic retinopathy which damages the retina due to complications of diabetes.

• Key Features:

• Focus on early detection and use of high-speed indocyanine green angiography for management.

3. Flashes and Floaters

• Description: Assessment and management of symptoms commonly associated with retinal issues.

• Key Features:

• Comprehensive retina examinations facilitated through advanced imaging techniques.

4. Retinal Detachment

• Description: Provides surgical treatment options for retinal detachment.

• Key Features:

• Pioneers in developing new surgical techniques for retinal reattachment.

5. Macular Pucker, Uveitis, Endophthalmitis, Macular Holes, CMV Retinitis

• Description: Diagnosis and treatment of these specific retinal conditions.

Technologies Used

• NAVILAS Navigated Retina Laser System

• Fluorescein Angiography (FA)

• Optical Coherence Tomography (OCT)

• Electroretinogram (ERG)

• B-Scan ultrasonography

Recent Developments

• Recent Activities:

• Participation in clinical trials introducing new technology and medication for conditions like Advanced Macular Degeneration and Diabetic Retinopathy.

• Recognition as a leader in eye care and ocular health through significant clinical research advancements.

• Continued introduction of state-of-the-art surgical techniques and medications.

• New Product Launches: No information is available

• New Features Added: No information is available

• Partnerships: No information is available

Locations

• Columbia:

• Address: 6325 Woodside Court, Suite 125, Columbia, Maryland 21046

• Phone: (410) 919-4455

• Owings Mills:

• Address: 21 Crossroads Drive, Suite 425, Owings Mills, MD 21117

• Phone: (410) 337-4500

• Olney:

• Address: 5420 Olney Laytonsville Road, Olney, MD 20832

• Phone: (410) 919-4455

Clinical Trials

• Participation Benefits:

• Access to new treatments and close monitoring

• Potential financial benefits

• Opportunities for receiving treatments not covered by insurance

• Participants gain from exams, lab tests, medications, and possible reimbursement for travel.

• Criteria: Participation requires meeting specific guidelines based on factors like disease stage, age, gender, and previous treatment history.

This report aims to provide a comprehensive overview of the National Retina Institute's operations, history, available treatments, and contributions to ocular health advancements through clinical trials.